Search results
Health Care Roundup: Market Talk
The Wall Street Journal· 7 days agoAstraZeneca’s growth drivers were its key drugs Farxiga, lung cancer drug Tagrisso and autoimmune disease drug Soliris, which offset ...
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 7 days agoThe new lupus drug, Saphnelo, recorded sales of $91 million in the quarter compared with $89 million...
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
Yahoo Finance· 6 days agoThe company's mid-term pipeline strategy will be important, as some investors remain concerned about...
AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance
Benzinga via Yahoo Finance· 7 days agoThursday, AstraZeneca Plc (NASDAQ:AZN) reported first-quarter sales of $12.68 billion, up 17% year...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 6 days agoVoydeya is approved for 10-20% of...C5 inhibitors. Voydeya’s approval is based on data from the...
JD Supra: Update on biosimilars in Canada – March 2024
JD Supra· 5 days agoIn this article, we provide a further update on developments regarding biosimilars in Canada (approvals, pending submissions, litigation, regulatory, and market access) since our March...
20 Fastest Growing Health Tech Companies in the World
Insider Monkey via Yahoo Finance· 7 days agoIn this article, we will be taking a look at the 20 fastest growing health tech companies in the...
What Are the New Treatments for Myasthenia Gravis?
Healthline· 6 days agoTreatments for myasthenia gravis have come a long way in helping people live longer, healthier lives. Current treatments — and those in development — can...
Venable’s BiologicsHQ Monthly Injection - April 2024 | JD Supra
JD Supra· 23 hours agoLatest News
